Gemeinschaftspraxis Faghih-Friedrichs-Zühlke

At Gemeinschaftspraxis Faghih-Friedrichs-Zühlke in Essen, a major share of the clinical research focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease, heart failure, hypertension, and hypercholesterolemia. These studies are designed to assess new ways to lower cardiovascular risk, reduce major heart and stroke events, and improve long-term disease control.

• Testing new approaches to reduce major adverse cardiovascular events in people with established heart and blood vessel disease
• Evaluating treatments that lower LDL cholesterol and other harmful blood lipids
• Studying therapies aimed at preventing heart failure events and improving outcomes in high-risk patients
• Assessing options for better blood pressure control in people with hypertension and elevated cardiovascular risk

This area reflects a strong emphasis on prevention, risk reduction, and improving treatment effectiveness for patients with chronic cardiovascular conditions.

Research at this site also includes hormonal diseases, with a particular focus on type 2 diabetes mellitus and obesity-related heart conditions such as HFpEF and HFmrEF. The trials in this field are exploring whether new therapies can improve safety, support metabolic control, and lower the risk of complications linked to diabetes and excess weight.

• Evaluating treatments for type 2 diabetes with attention to safety and tolerability
• Studying therapies for patients with heart failure and obesity-related disease
• Exploring whether new medicines can reduce cardiovascular events in metabolically high-risk groups

The work in this area connects metabolic health with cardiovascular prevention, reflecting the close relationship between diabetes, obesity, and heart disease.

Another important research theme is respiratory tract disease, with studies centered on respiratory syncytial virus and human metapneumovirus in older adults. These trials are focused on prevention, especially reducing the burden of lower respiratory tract illness in people who may be more vulnerable to infection.

• Preventing RSV and hMPV lower respiratory tract disease in adults aged 60 and older
• Improving protection against seasonal respiratory infections in older populations

This line of research supports better infection prevention strategies for aging patients and aims to reduce respiratory complications.

The site also participates in research on digestive system diseases, particularly chronic constipation. These studies are intended to evaluate the safety and tolerability of long-term treatment and to support more reliable symptom management for patients with ongoing bowel disorders.

• Assessing long-term treatment options for chronic constipation
• Exploring whether therapy can provide sustained symptom relief with acceptable safety

This research area is smaller than the cardiovascular program but remains clinically important for improving everyday quality of life.